Changes for page Ajanta Pharma Ltd

Last modified by Asif Farooqui on 2021/03/15 15:40
From version < 7.1 >
edited by Asif Farooqui
on 2021/03/15 15:39
To version < 8.1
edited by Asif Farooqui
on 2021/03/15 15:40
<
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -20,6 +20,10 @@
20 20  
21 21  The company employ over 7,000+ people worldwide and its products are sold in over 30 countries. Ajanta’s team members are driven to fulfill its mission; a commitment to ‘Serving Global Healthcare needs with Empathy, Innovation & Technology’.
22 22  
23 +
24 +[[image:AJANTPHARM.jpg]]
25 +
26 +
23 23  **Plant locations**{{footnote}}http://ajantapharma.com/manufacturing.html{{/footnote}}
24 24  
25 25  DAHEJ. GUJARAT:- Dosage Forms Tablets. Capsules. Powder Jelly
... ... @@ -38,8 +38,6 @@
38 38  
39 39  CHITEGAON, AURANGABAD:-Dosage Forms : Tablets. Capsules. Powder & Jelly
40 40  
41 -{{putFootnotes/}}
42 -
43 43  = Industry Overview =
44 44  
45 45  The pharmaceutical industry is one of the world’s fastest growing industries and among the biggest contributors to the world economy. It plays a unique role in improving the lives of patients. Its role has become far more critical amidst the fight against COVID -19 pandemic.{{footnote}}http://ajantapharma.com/AdminData/AnnualReports/AnnualReportFY2019-20.pdf{{/footnote}}
... ... @@ -122,6 +122,19 @@
122 122  
123 123  During Q4 FY 2019, R&D expenses were Rs. 40 cr., (Q4 FY 2018 Rs. 47 cr.) which is 8% of operating revenue. For FY 2019, R&D expenses were Rs. 176 cr., (FY 2018 Rs. 185 cr.) which is 9% of operating revenue.
124 124  
127 +
128 += Recent developments =
129 +
130 +**Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y **{{footnote}}https://www.moneycontrol.com/news/business/earnings/ajanta-pharma-consolidated-december-2020-net-sales-at-rs-748-74-crore-up-14-98-y-o-y-6437461.html{{/footnote}}
131 +
132 +**February 02, 2021** Reported Consolidated quarterly numbers for Ajanta Pharma are:
133 +
134 +* Net Sales at Rs 748.74 crore in December 2020 up 14.98% from Rs. 651.21 crore in December 2019.
135 +* Quarterly Net Profit at Rs. 176.63 crore in December 2020 up 64.23% from Rs. 107.55 crore in December 2019.
136 +* EBITDA stands at Rs. 247.16 crore in December 2020 up 23.2% from Rs. 200.61 crore in December 2019.
137 +* Ajanta Pharma EPS has increased to Rs. 20.41 in December 2020 from Rs. 12.33 in December 2019.
138 +
139 +
125 125  = References =
126 126  
127 127  {{putFootnotes/}}
This site is funded and maintained by Fintel.io